Delivery Order SPE2DB22D2103-SPE2DB25FR9FH

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0UR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,751.48 delivery order contract is for the supply of 4,567,956,496 units of the drug Modafinil 100 mg tablet, with a firm fixed price and an ultimate completion date of April 18, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp...
This federal contract award, identified as SPE2DB20D3505|SPE2DB25FU4K8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.74 delivery order contract is for the supply of 4,567,985,623 units of Modafinil 100 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp, the prime contractor, holds a...
This federal contract award, valued at $2,054.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,962,528 units of the medication Modafinil 100 mg tablet in 30-count packages. The contract has an ultimate completion date of April 21, 2025 and a firm fixed price pricing type. This award is not associated with a set-aside designation,...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEJA9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,110.41 firm fixed-price delivery order is for the supply of 4,567,943,049 units of the prescription medication modafinil 100 mg tablets. The contract has an ultimate completion date of April 17, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,950 units of the prescription medication Modafinil 100 mg tablets, with a total ceiling value of $6,649.90. The contract type is a Delivery Order and the pricing is Firm Fixed Price. This contract is not designated as a set-aside and is open to full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,017.80 firm fixed-price delivery order is for the supply of 4,567,958,498 units of the prescription medication modafinil 100 mg tablets. The contract has an ultimate completion date of April 21, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG0JL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,753.48 firm fixed-price delivery order is for the supply of 4,567,944,125 units of the prescription medication Modafinil 100 mg tablets. The contract has an ultimate completion date of April 17, 2025 and does not utilize any set-aside designations, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,345.20, is for the delivery of Modafinil 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2025. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, has extensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,376.74 firm fixed-price delivery order is for the supply of 4,567,618,550 tablets of Modafinil 100 mg, a generic medication. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6MSA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,548.30 firm fixed-price delivery order is for the supply of 4,568,058,137 units of the prescription medication Modafinil 100 mg tablets. The contract has an ultimate completion date of April 29, 2025 and is not set aside for any specific business type. Amerisourcebergen...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR9FH
    Delivery Order

This federal contract award, with ID SPE2DB22D2103|SPE2DB25FR9FH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,175,274 units of the drug modafinil 100 mg tablets, with a ceiling value of $7,724.51. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of May 8, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract enables Amerisourcebergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/6/25, 10:02 AM